Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action

Introduction: MDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, is a novel, rapid-acting antidepressant, however the mechanism...

Full description

Saved in:
Bibliographic Details
Main Authors: Madison N. Irwin, PharmD (Author), Amy VandenBerg, PharmD, BCPP (Author)
Format: Book
Published: American Association of Psychiatric Pharmacists, 2021-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available